Apotex Appeals Abbott Depakote Ruling

Law360, New York (April 14, 2004, 12:00 AM EDT) -- Canadian drug maker Apotex has filed an appeal to the U.S. Court of Appeals for the Federal Circuit of a U.S. District Court ruling that found its generic divalproex sodium had infringed Abbott Laboratories' intellectual property covering epilepsy drug Depakote.

Apotex's appeal is based on the claim that the district court judge “unduly restricted the scope of the trial and Apotex's evidence,” the company said.

In March, a judge with the U.S. District Court for the Northern District of Illinois ruled that TorPharm's generic product infringes...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.